These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10348793

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic fibrosis does not affect the pharmacokinetics of 5-fluorouracil in rats.
    Nagata M, Hidaka Y, Hatakeyama K, Kawano Y, Iwakiri T, Okumura M, Arimori K.
    Biopharm Drug Dispos; 2011 Mar; 32(2):126-30. PubMed ID: 21341281
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Parenteral nutrition decreases hepatic dihydropyrimidine dehydrogenase activity and modulates catabolism of 5-fluorouracil in rats.
    Taniguchi M, Yano M, Tsujinaka T, Ogawa A, Morita S, Kaneko K, Akiyama Y, Miki H, Monden M.
    In Vivo; 2003 Mar; 17(3):219-23. PubMed ID: 12929570
    [Abstract] [Full Text] [Related]

  • 6. 5-fluorouracil sensitivity and dihydropyrimidine dehydrogenase activity in advanced gastric cancer.
    Inada T, Ogata Y, Kubota T, Tomikawa M, Yamamoto S, Andoh J, Ozawa I, Hishinuma S, Shimizu H, Kotake K.
    Anticancer Res; 2000 Mar; 20(4):2457-62. PubMed ID: 10953310
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S, Yamasaki H, Kitayama Y, Okada T, Maeda S.
    Oncol Rep; 2003 Mar; 10(1):109-13. PubMed ID: 12469154
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [Abstract] [Full Text] [Related]

  • 10. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
    Okuda H, Ogura K, Kato A, Takubo H, Watabe T.
    J Pharmacol Exp Ther; 1998 Nov; 287(2):791-9. PubMed ID: 9808711
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Dihydropyrimidine dehydrogenase activity in lymphocytes: predictive factor for 5-fluorouracil clearance].
    Etienne MC, Milano G, Fleming RA, Thyss A, Renée N, Schneider M, Demard F.
    Bull Cancer; 1992 Dec; 79(12):1159-63. PubMed ID: 1304835
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of PR-350, a newly developed radiosensitizer, on dihydropyrimidine dehydrogenase activity and 5-fluorouracil pharmacokinetics.
    Watanabe M, Tateishi T, Takezawa N, Tanaka M, Kumai T, Nakaya S, Kobayashi S.
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):250-4. PubMed ID: 11320669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.